SCHEMBL22925271

SCHEMBL22925271

c1ccc(-c2ccc(-c3nc(-c4ccccc4-c4cccc5c4oc4c(-c6ccccc6)cccc45)nc(-c4ccccc4-c4cccc5c4oc4c(-c6ccc(-c7ccccc7)cc6)cccc45)n3)cc2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.41
KDM4E B2RXH2 4/20 0.41
MAPT P10636 4/20 0.41
TSHR P16473 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
HPGD P15428 3/20 0.41
ATM Q13315 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
TP53 P04637 2/20 0.41
NFKB1 P19838 2/20 0.41
HSD17B10 Q99714 2/20 0.41
MAPK1 P28482 1/20 0.41
NFKB2 Q00653 1/20 0.41
RELA Q04206 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
PRKDC P78527 5/20 0.40
PIK3CB P42338 4/20 0.40
PIK3CG P48736 4/20 0.40
PIK3CD O00329 3/20 0.40
PIK3CA P42336 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21425196 0.97 ALDH1A1 (0.43) ALDH1A1KDM4EMAPTTSHRSMN1; SMN2
SCHEMBL23975325 0.95 GPR55 (0.42) ALDH1A1KDM4EMAPTTSHRSMN1; SMN2
SCHEMBL17425705 0.95 ALDH1A1 (0.44) ALDH1A1KDM4EMAPTTSHRSMN1; SMN2
SCHEMBL24216935 0.95 ALDH1A1 (0.44) ALDH1A1KDM4EMAPTTSHRSMN1; SMN2
SCHEMBL17425793 0.95 ALDH1A1 (0.44) ALDH1A1KDM4EMAPTTSHRSMN1; SMN2
SCHEMBL24525894 0.95 ALDH1A1 (0.44) ALDH1A1KDM4EMAPTTSHRSMN1; SMN2
SCHEMBL24217269 0.95 ALDH1A1 (0.44) ALDH1A1KDM4EMAPTTSHRSMN1; SMN2
SCHEMBL17425653 0.95 ALDH1A1 (0.44) ALDH1A1KDM4EMAPTTSHRSMN1; SMN2
SCHEMBL17425706 0.95 ALDH1A1 (0.44) ALDH1A1KDM4EMAPTTSHRSMN1; SMN2
SCHEMBL25645846 0.95 ALDH1A1 (0.44) ALDH1A1KDM4EMAPTTSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210340103-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC APPARATUS THEREOF DUK SAN NEOLUX CO., LTD (KR) 2021-11-04 US disclosed
US-20210184129-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD (KR) 2021-06-17 US disclosed
US-20210028370-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING THE SAME, AND ELECTRONIC DEVICE THEREFOR DUK SAN NEOLUX CO., LTD. (KR) 2021-01-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210028370-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING THE SAME, AND ELECTRONIC DEVICE THEREFOR OR51E2, WEE1, SLC39A11 ALDH1A1 1905/4885KDM4E 1966/4885MAPT 2705/4885
US-20210340103-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC APPARATUS THEREOF OR51E2, SLC39A11, WEE1 ALDH1A1 1489/4885KDM4E 1772/4885MAPT 1837/4885
US-20210184129-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME AND ELECTRONIC DEVICE THEREOF OR51E2, SLC39A11, WEE1 ALDH1A1 2143/4885KDM4E 1068/4885MAPT 1639/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.